PACS Group Appoints New CMO, Grants Stock Options
Ticker: PACS · Form: 8-K · Filed: Jun 21, 2024 · CIK: 2001184
Sentiment: neutral
Topics: executive-appointment, stock-options, board-of-directors
TL;DR
PACS Group names new CMO, gives him 150k shares/options.
AI Summary
PACS Group, Inc. announced on June 19, 2024, a series of significant executive and board changes. The company appointed Dr. David L. Smith as Chief Medical Officer and elected him to the Board of Directors. Additionally, Dr. Smith was granted 100,000 stock options and 50,000 restricted stock units, vesting over three years, with a strike price of $0.01 per share.
Why It Matters
The appointment of a Chief Medical Officer and the associated stock grants signal a strategic move by PACS Group to bolster its medical leadership and align executive incentives with company performance.
Risk Assessment
Risk Level: medium — Executive appointments and stock option grants can introduce new dynamics and potential dilution, requiring careful monitoring.
Key Numbers
- 100,000 — Stock Options Granted (Awarded to new Chief Medical Officer, Dr. David L. Smith.)
- 50,000 — Restricted Stock Units Granted (Awarded to new Chief Medical Officer, Dr. David L. Smith.)
- $0.01 — Stock Option Strike Price (The price at which Dr. Smith can purchase shares.)
Key Players & Entities
- PACS Group, Inc. (company) — Registrant
- Dr. David L. Smith (person) — Appointed Chief Medical Officer and elected to Board of Directors
- 100,000 stock options (dollar_amount) — Granted to Dr. Smith
- 50,000 restricted stock units (dollar_amount) — Granted to Dr. Smith
- $0.01 (dollar_amount) — Strike price for stock options
- June 19, 2024 (date) — Date of report
FAQ
What are the specific responsibilities of Dr. David L. Smith as Chief Medical Officer?
The filing does not detail the specific responsibilities of Dr. David L. Smith as Chief Medical Officer, only his appointment and compensation.
What is the vesting schedule for the stock options and restricted stock units granted to Dr. Smith?
The stock options and restricted stock units granted to Dr. Smith vest over three years.
What is the total number of equity awards granted to Dr. Smith?
Dr. Smith was granted a total of 150,000 equity awards (100,000 stock options and 50,000 restricted stock units).
When was Dr. David L. Smith elected to the Board of Directors?
Dr. David L. Smith was elected to the Board of Directors on June 19, 2024.
What is the stated purpose of the equity grants to Dr. Smith?
The filing states the grants are part of his compensatory arrangements, but does not elaborate on specific performance-based incentives beyond the vesting schedule.
Filing Stats: 458 words · 2 min read · ~2 pages · Grade level 13.1 · Accepted 2024-06-21 16:57:47
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share PACS The New York S
Filing Documents
- pacs-20240619.htm (8-K) — 27KB
- 0002001184-24-000030.txt ( ) — 146KB
- pacs-20240619.xsd (EX-101.SCH) — 2KB
- pacs-20240619_lab.xml (EX-101.LAB) — 21KB
- pacs-20240619_pre.xml (EX-101.PRE) — 12KB
- pacs-20240619_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PACS GROUP, INC. Date: June 21, 2024 By: /s/ John Mitchell John Mitchell Chief Legal Officer